A Busy Week For Bio-Pharma Earnings, Drug Approvals

A Busy Week For Bio-Pharma Earnings, Drug Approvals

Submitted by admin on July 23, 2012 - 9:15am
Source: 
TheStreet.com
News Tags: 
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Headline: 
A Busy Week For Bio-Pharma Earnings, Drug Approvals

Do Not Allow Advertisers to Use My Personal information